B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Activation of AMPK downstream of NMDARs

REACTOME PATHWAY
Reactome: R-HSA-961948325 genes25 compounds

The Activation of AMPK downstream of NMDARs pathway (Reactome ID: R-HSA-9619483) involves 25 genes and is affected by 25 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CAMKK2PRKAA1PRKAA2PRKAB1PRKAB2PRKAG1PRKAG2PRKAG3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBA8TUBAL3TUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TUBB8B

Compounds Affecting Activation of AMPK downstream of NMDARs

#CompoundTargets HitStudies
1Colchicine300
2Nocodazole Nocodazole is215
3Vincristine299
4Noscapine300
5Podophyllotoxin14
6Demecolcine246
7Maytansine300
8vinblastine sulfate81
9Vorinostat299
10Adenosine Monophosphate Adenine nucleotide containing300
11Proguanil299
12Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone76
13Niclosamide299
14Berberine300
15Ursolic Acid300
16Antimycin300
17Oleanolic Acid300
18Rotenone300
19Metformin1,000
20Crizotinib298
21Quercetin300
22Kaempferols300
23Rutin300
24sp600125117
25Axitinib298

About the Activation of AMPK downstream of NMDARs Pathway

The Activation of AMPK downstream of NMDARs pathway is catalogued in Reactome (ID: R-HSA-9619483) and involves 25 genes. In the BiohacksAI corpus, 25 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CAMKK2, PRKAA1, PRKAA2, PRKAB1, PRKAB2.